CN103083573A - 一种治疗酒精性脂肪肝的中药 - Google Patents
一种治疗酒精性脂肪肝的中药 Download PDFInfo
- Publication number
- CN103083573A CN103083573A CN2013100432674A CN201310043267A CN103083573A CN 103083573 A CN103083573 A CN 103083573A CN 2013100432674 A CN2013100432674 A CN 2013100432674A CN 201310043267 A CN201310043267 A CN 201310043267A CN 103083573 A CN103083573 A CN 103083573A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- chinese medicine
- liver
- fatty liver
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 31
- 208000010706 fatty liver disease Diseases 0.000 title claims abstract description 27
- 208000007082 Alcoholic Fatty Liver Diseases 0.000 title claims abstract description 20
- 206010016262 Fatty liver alcoholic Diseases 0.000 title claims abstract description 20
- 208000026594 alcoholic fatty liver disease Diseases 0.000 title claims abstract description 20
- 244000019459 Cynara cardunculus Species 0.000 claims abstract description 12
- 235000019106 Cynara scolymus Nutrition 0.000 claims abstract description 12
- 240000000785 Tagetes erecta Species 0.000 claims abstract 3
- 235000005881 Calendula officinalis Nutrition 0.000 claims description 11
- 239000009526 Fructus Akebiae Substances 0.000 claims description 9
- 229940079593 drug Drugs 0.000 claims description 5
- 241000722953 Akebia Species 0.000 claims description 2
- 241000238370 Sepia Species 0.000 claims description 2
- 239000000203 mixture Substances 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- GNKZMNRKLCTJAY-UHFFFAOYSA-N 4'-Methylacetophenone Chemical compound CC(=O)C1=CC=C(C)C=C1 GNKZMNRKLCTJAY-UHFFFAOYSA-N 0.000 abstract 1
- 240000008027 Akebia quinata Species 0.000 abstract 1
- 235000007756 Akebia quinata Nutrition 0.000 abstract 1
- 241001016465 Asplenium rhizophyllum Species 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 240000000366 Melilotus officinalis Species 0.000 abstract 1
- 235000017822 Melilotus officinalis Nutrition 0.000 abstract 1
- 241000219925 Oenothera Species 0.000 abstract 1
- 235000004496 Oenothera biennis Nutrition 0.000 abstract 1
- 244000153955 Reynoutria sachalinensis Species 0.000 abstract 1
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 abstract 1
- 241000967256 Swertia punicea Species 0.000 abstract 1
- 235000012311 Tagetes erecta Nutrition 0.000 abstract 1
- 235000003595 Tagetes minuta Nutrition 0.000 abstract 1
- 240000008042 Zea mays Species 0.000 abstract 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 abstract 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 abstract 1
- 235000016520 artichoke thistle Nutrition 0.000 abstract 1
- 235000005822 corn Nutrition 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 18
- 230000001737 promoting effect Effects 0.000 description 14
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 210000000232 gallbladder Anatomy 0.000 description 12
- 241000736851 Tagetes Species 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 230000036407 pain Effects 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 208000004930 Fatty Liver Diseases 0.000 description 7
- 206010019708 Hepatic steatosis Diseases 0.000 description 7
- 231100000240 steatosis hepatitis Toxicity 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 6
- 206010023126 Jaundice Diseases 0.000 description 5
- 230000003908 liver function Effects 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 208000037920 primary disease Diseases 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 208000022309 Alcoholic Liver disease Diseases 0.000 description 2
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 2
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 201000001352 cholecystitis Diseases 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000033386 Buerger disease Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 206010009208 Cirrhosis alcoholic Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 108020004206 Gamma-glutamyltransferase Proteins 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 206010019728 Hepatitis alcoholic Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 201000009053 Neurodermatitis Diseases 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010043540 Thromboangiitis obliterans Diseases 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 208000002353 alcoholic hepatitis Diseases 0.000 description 1
- 208000010002 alcoholic liver cirrhosis Diseases 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 102000006640 gamma-Glutamyltransferase Human genes 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310043267.4A CN103083573B (zh) | 2013-01-20 | 2013-01-20 | 一种治疗酒精性脂肪肝的中药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310043267.4A CN103083573B (zh) | 2013-01-20 | 2013-01-20 | 一种治疗酒精性脂肪肝的中药 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103083573A true CN103083573A (zh) | 2013-05-08 |
CN103083573B CN103083573B (zh) | 2014-04-02 |
Family
ID=48197051
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310043267.4A Expired - Fee Related CN103083573B (zh) | 2013-01-20 | 2013-01-20 | 一种治疗酒精性脂肪肝的中药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103083573B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105497598A (zh) * | 2014-11-07 | 2016-04-20 | 苏珉 | 一种治疗酒精性脂肪肝的中药 |
CN105497509A (zh) * | 2014-11-07 | 2016-04-20 | 苏珉 | 一种治疗脂肪肝的中药 |
CN115212253A (zh) * | 2022-08-05 | 2022-10-21 | 南京中医药大学 | 一种治疗肝纤维化的中药复方制剂及其制备方法与应用 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101199668A (zh) * | 2006-12-11 | 2008-06-18 | 孙蓉 | 一种治疗酒精性脂肪肝的中药制剂及其制备方法 |
CN101199714A (zh) * | 2006-12-11 | 2008-06-18 | 孙蓉 | 一种治疗酒精性脂肪肝的中药组合物及其制备方法 |
CN101450131A (zh) * | 2007-12-03 | 2009-06-10 | 陈海生 | 一种中药组合物的药物新用途 |
CN102488850A (zh) * | 2011-12-31 | 2012-06-13 | 黄文珍 | 治疗酒精性脂肪肝的中药组合物及其制备方法 |
CN102688451A (zh) * | 2012-05-25 | 2012-09-26 | 王兴辉 | 一种治疗酒精性脂肪肝的中药组合物 |
CN102784366A (zh) * | 2012-09-03 | 2012-11-21 | 赵全成 | 一种具有醒酒保肝作用的药物组合物 |
-
2013
- 2013-01-20 CN CN201310043267.4A patent/CN103083573B/zh not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101199668A (zh) * | 2006-12-11 | 2008-06-18 | 孙蓉 | 一种治疗酒精性脂肪肝的中药制剂及其制备方法 |
CN101199714A (zh) * | 2006-12-11 | 2008-06-18 | 孙蓉 | 一种治疗酒精性脂肪肝的中药组合物及其制备方法 |
CN101450131A (zh) * | 2007-12-03 | 2009-06-10 | 陈海生 | 一种中药组合物的药物新用途 |
CN102488850A (zh) * | 2011-12-31 | 2012-06-13 | 黄文珍 | 治疗酒精性脂肪肝的中药组合物及其制备方法 |
CN102688451A (zh) * | 2012-05-25 | 2012-09-26 | 王兴辉 | 一种治疗酒精性脂肪肝的中药组合物 |
CN102784366A (zh) * | 2012-09-03 | 2012-11-21 | 赵全成 | 一种具有醒酒保肝作用的药物组合物 |
Non-Patent Citations (3)
Title |
---|
李艳杰等: "复方参草颗粒对大鼠酒精性脂肪肝的拮抗作用", 《吉林大学学报(医学版)》 * |
杨玺: "《脂肪肝用药知识》", 31 July 2011, 金盾出版社 * |
赵昱等: "天然药物防治非酒精性和酒精性脂肪肝的研究进展", 《国际药学研究杂志》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105497598A (zh) * | 2014-11-07 | 2016-04-20 | 苏珉 | 一种治疗酒精性脂肪肝的中药 |
CN105497509A (zh) * | 2014-11-07 | 2016-04-20 | 苏珉 | 一种治疗脂肪肝的中药 |
CN115212253A (zh) * | 2022-08-05 | 2022-10-21 | 南京中医药大学 | 一种治疗肝纤维化的中药复方制剂及其制备方法与应用 |
CN115212253B (zh) * | 2022-08-05 | 2023-04-11 | 南京中医药大学 | 一种治疗肝纤维化的中药复方制剂及其制备方法与应用 |
Also Published As
Publication number | Publication date |
---|---|
CN103083573B (zh) | 2014-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102552793B (zh) | 治疗老年冠心病不稳定心绞痛的中药组合物 | |
CN104474471A (zh) | 一种治疗甲状腺的中药组合物 | |
CN103432559B (zh) | 一种治疗血滞型月经减少及痛经的中药组合物及其制备方法和用途 | |
CN103977366A (zh) | 一种治疗慢性胆囊炎的药物 | |
CN103083573B (zh) | 一种治疗酒精性脂肪肝的中药 | |
CN103041410A (zh) | 一种用于胃肠道超声诊断的造影粉剂 | |
CN104306929A (zh) | 一种治疗重症急性胰腺炎的中药配方及其制备方法 | |
CN102688451B (zh) | 一种治疗酒精性脂肪肝的中药组合物 | |
CN103877420A (zh) | 一种治疗酒精性脂肪肝的中药 | |
CN105031487A (zh) | 一种治疗湿困脾胃型小儿黄疸的中药组合物 | |
CN104940507A (zh) | 一种治疗肝血管瘤的中药制剂 | |
CN103990019A (zh) | 一种治疗头晕目眩的中药药剂 | |
CN104116983A (zh) | 一种预防月子病的口服液 | |
CN103877226B (zh) | 具有滋肝补肾功效的豆腐黄鳝粥品及其制备方法 | |
CN108114118A (zh) | 一种治疗偏头痛的穴位贴 | |
CN106822852A (zh) | 治疗冠心病的药物组合物、其制备工艺及用途 | |
CN105998781A (zh) | 一种治疗急性胃肠炎的药物组合物 | |
CN105770832A (zh) | 治疗腹胀的中药组合物 | |
CN103520584A (zh) | 一种治疗新生儿黄疸的中药及制备方法 | |
CN105435103A (zh) | 一种治疗脾虚痰阻型闭经溢乳综合征的中药 | |
CN104707029B (zh) | 一种治疗银屑病的中药 | |
CN104435117A (zh) | 一种治疗淋巴管瘤的中药组合物 | |
CN104225506A (zh) | 用于治疗化疗后血小板减少的药物制剂 | |
CN103519215A (zh) | 具有治疗肝硬化腹水功效的汤鸡 | |
CN102406829A (zh) | 一种治疗胸痛的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: LI XIAOQIN Free format text: FORMER OWNER: CUI YINGKUN Effective date: 20140228 |
|
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Xiaoqin Inventor after: Cui Yingkun Inventor after: Cai Lingling Inventor before: Cui Yingkun Inventor before: Li Xiaoqin |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: CUI YINGKUN LI XIAOQIN TO: LI XIAOQIN CUI YINGKUN CAI LINGLING |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20140228 Address after: 262500 Shandong province Qingzhou City Linglong Mountain Road No. 3888 Qingzhou Invalides hospital Applicant after: Li Xiaoqin Address before: 262500 Shandong province Qingzhou City Linglong Mountain Road No. 3888 Qingzhou Invalides hospital Applicant before: Cui Yingkun |
|
TA01 | Transfer of patent application right | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: NANTONG HONGCI PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: LI XIAOQIN Effective date: 20140911 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 262500 WEIFANG, SHANDONG PROVINCE TO: 226200 NANTONG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140911 Address after: 226200 chemical industry park, Nantong, Jiangsu, Qidong Patentee after: NANTONG HONGCI PHARMACEUTICAL CO., LTD. Address before: 262500 Shandong province Qingzhou City Linglong Mountain Road No. 3888 Qingzhou Invalides hospital Patentee before: Li Xiaoqin |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140402 Termination date: 20190120 |